COMMUNIQUÉS West-GlobeNewswire

European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors
26/04/2019
– Major Advance in the Treatment of European Factor Xa Inhibitor Patients Hospitalized with Life-Threatening Bleeding – – Initial Launch in Select Countries to Begin 2H 2019 – SOUTH SAN FRANCISCO, Calif., April 26, 2019 [...]
CB2 Insights to Host FY2018 Earnings Call on May 1, 2019
26/04/2019
TORONTO, April 26, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its fiscal year [...]
Aequus Announces Filing of Prospectus Supplement and an Update to Previously Announced Public Offering of Convertible Debenture Units
26/04/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 26, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (the “ Company ”) (TSX-V: [...]
Nexstim Plc: Managers' Transactions
26/04/2019
Company announcement, Helsinki, 26 April 2019 at 4pm (EET) Nexstim Plc: Managers' Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and marketing [...]
Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run
26/04/2019
The community is invited to walk to support the March of Dimes mission for healthy moms and babies CARY, N.C., April 26, 2019 (GLOBE NEWSWIRE) -- Chiesi is proud to return as the signature sponsor of the 2019 Triangle [...]
Wildflower Featured in CannabisNewsAudio Broadcast Examining Rare Opportunities for Profit in Cannabis Market
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, “The Cannabis Bonanza Has Just [...]
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018
26/04/2019
DENVER, CO, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare solutions company, today [...]
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
26/04/2019
European Commission Approval Anticipated Within 90 Days NEWPORT BEACH, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on [...]
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
26/04/2019
In an experimental back of the eye, autoimmune uveitis (EAU) model to be reported in a poster presentation at ARVO 2019, nomacopan (Coversin) and its long acting variants administered intravitreally, reported: ○ [...]
miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru
26/04/2019
Continued evidence of disease stabilization observed in ATLL patients treated with cobomarsen for up to 16 months Cobomarsen allowed for rapid bone marrow recovery following chemotherapy In most patients, biomarkers [...]
111 to Announce First Quarter 2019 Unaudited Financial Results on May 16, 2019
26/04/2019
SHANGHAI, China, April 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its [...]
Annual Report 2018 Active Biotech AB (publ)
26/04/2019
PRESS RELEASE Active Biotech's Annual Report 2018 is now available for download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. [...]
Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes
26/04/2019
Bagsværd, Denmark, 26 April 2019 - Novo Nordisk today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like peptide-1 (GLP-1 [...]
Vistin Pharma ASA: Annual Report 2018
26/04/2019
Oslo, 26 April 2019 Please find attached the Annual Report for 2018 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 19 February [...]
C-RAD and OPASCA announce strategic partnership
26/04/2019
C-RAD, providing cutting-edge solutions ensuring exceptionally high precision, safety and efficiency in advanced radiation therapy, and OPASCA, the leader in innovative patient safety and workflow management solutions [...]
Notice of annual shareholders’ meeting in Saniona AB
26/04/2019
PRESS RELEASE April 26, 2019 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona [...]
Motif Bio plc: Notice of Annual General Meeting
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc ("Motif Bio" or the "Company") (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that [...]
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote “FOR” Proposed Acquisition by Biogen
26/04/2019
WALTHAM, Mass. and LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc ("Nightstar") (NASDAQ: NITE) today announced that both leading independent proxy advisory firms, Institutional Shareholder [...]
Motif Bio Announces Appointment of Andrew Powell to Board of Directors
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced the [...]

Pages